CompoAtlas

Vitalité Masculine 2 en 1

Food supplement declared in France, declaration No 2024-1-1519, decision dated 30 January 2024

Vitalité Masculine 2 en 1 (Poméol) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Cucurbita pepo 125 mg per day, Turnera diffusa 100 mg per day, Malus pumila 100 mg per day, Serenoa repens 100 mg per day, Prunus africana 30 mg per day. 3 rules of use apply to its ingredients (limits and warnings).

Brand
Poméol
Food business operator placing the product on the market
LABORATOIRES CLÉMASCIENCE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2 gélules
Directions for use
2 gélules par jour, le matin, avec un grand verre d'eau.
Intended populations
Men
Not recommended (according to the manufacturer)
Adolescents (under 18), Taking anticoagulants, Taking antidepressants, Taking diabetes medication, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Sexual vitality, Urinary system

Declaration 306572, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Cucurbita pepo L.GermeExtrait sec hydroalcoolique125 mg
Turnera diffusa Willd. ex Schult.FeuilleExtrait sec hydroalcoolique100 mg
Malus pumila Mill.FruitExtrait sec hydroalcoolique100 mg
Serenoa repens (W.Bartram) SmallFruitAutre extrait sec100 mg
Prunus africana (Hook. f.) KalkmanEcorceExtrait sec hydroalcoolique30 mg
Crocus sativus L.StigmatesExtrait sec hydroalcoolique30 mg
Zingiber officinale RoscoeRhizomeExtrait sec hydroalcoolique20 mg
Epilobium angustifolium L.Parties aériennesExtrait sec aqueux10 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
L-selenomethionineSelenium255 µg50 µg
pyridoxine hydrochlorideVitamin B612 mg2 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
zinc citrateZinc25 mg15 mg

Additives

E464, E504, E553b, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne doivent pas se substituer à un régime alimentaire varié et équilibré. Réservé aux adultes. Déconseillé aux personnes sous traitement antidiabétique, antidépresseur ou en cas de calculs biliaires. En cas de traitements médicamenteux, en particulier anticoagulants ou des inhibiteurs de l'agrégation plaquettaire, demandez conseil à votre médecin et/ou à votre pharmacien. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des enfants. Conserver à l'abri de l'humidité, de la lumière et de la chaleur.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Serenoa repens (W.Bartram) Small
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Health Canada monograph dated 19 December 2025

  • Prunus africana (Hook. f.) Kalkman
    Read the warning, when it applies and the studies cited

    PYGEUM - PRUNUS AFRICANA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.

    Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 26 June 2026

  • Zingiber officinale Roscoe
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Poméol

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Vitalité Masculine 2 en 1 (Poméol): composition and regulation”, https://compoatlas.com/en/supplements/products/306572-vitalite-masculine-2-en-1, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line